2,294
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Inhibitors of Quinolinic Acid Synthesis: New Weapons in the Study of Neuroinflammatory Diseases

Pages 841-843 | Published online: 25 Jun 2014

References

  • Stone TW , StoyN, DarlingtonLG. An expanding range of targets for kynurenine metabolites of tryptophan. Trends Pharmacol. Sci.34 (2), 136–143 (2013).
  • Schwarcz R , BrunoJP, MuchowskiPJ, WuHQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci.13 (7), 465–477 (2012). 
  • Guillemin GJ . Quinolinic acid, the inescapable neurotoxin. FEBS J.279 (8), 1356–1365 (2012). 
  • Stone TW , PerkinsMN. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol.72, 411–412 (1981)
  • Schwarcz R , KöhlerC. Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci. Lett.38, 85–90 (1983).
  • Whetsell WO Jr , SchwarczR. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci. Lett.97, 271–275 (1989).
  • Beal M , KowallN, EllisonDet al. Replication of the neurochemical characteristics of Huntington’s disease by quinolinic acid. Nature321, 168–171 (1986).
  • Schwarcz R , GuidettiP, SathyasaikumarKV, MuchowskiPJ. Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington’s disease. Prog. Neurobiol.90 (2), 230–245 (2010).
  • Amori L , GuidettiP, PellicciariR, KajiiY, SchwarczR. On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo.J. Neurochem.109 (2), 316–325 (2009).
  • Pellicciari R , NataliniB, CostantinoGet al. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase. J. Med. Chem.37 (5), 647–655 (1994).
  • Röver S , CesuraAM, HugueninP, KettlerR, SzenteA. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase. J. Med. Chem.40 (26), 4378–4385 (1997).
  • Lee WS , LeeSM, KimMKet al. The tryptophan metabolite 3-hydroxyanthranilic acid suppresses T cell responses by inhibiting dendritic cell activation. Int. Immunopharmacol.17 (3), 721–726 (2013).
  • Fazio F , LionettoL, MolinaroGet al. Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors. Mol. Pharmacol.81 (5), 643–656 (2012).
  • Sahm F , OezenI, OpitzCAet al. The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress. Cancer Res.73 (11), 3225–3234 (2013).
  • Vallerini GP , AmoriL, BeatoCet al. 2-aminonicotinic acid 1-oxides are chemically stable inhibitors of quinolinic acid synthesis in the mammalian brain: a step toward new antiexcitotoxic agents. J. Med. Chem.56 (23), 9482–9495 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.